Bangor Savings Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25
Closed -$3.07K 580
2025
Q4
$3.07K Buy
+25
New +$3.04K ﹤0.01% 548
2017
Q3
Sell
-18,161
Closed -$1.28M 151
2017
Q2
$1.28M Buy
18,161
+4,201
+30% +$280K 0.28% 63
2017
Q1
$948K Buy
13,960
+161
+1% +$11.3K 0.21% 79
2016
Q4
$988K Sell
13,799
-8
-0.1% -$595 0.23% 75
2016
Q3
$1.09M Sell
13,807
-86
-0.6% -$6.99K 0.26% 69
2016
Q2
$1.16M Buy
+13,893
New +$1.23M 0.29% 67

Other funds holding GILD

Bangor Savings Bank's GILD Position: Q1 2026 in Review

Bangor Savings Bank sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 25 shares — an estimated $3.07K sold.

Bangor Savings Bank first reported a position in GILD in Q2 2016 and held it in 6 quarters. The position peaked at $1.28M in Q2 2017. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Bangor Savings Bank reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Bangor Savings Bank sold 25 Gilead Sciences shares in Q1 2026, an estimated $3.07K.
  • Bangor Savings Bank first reported a position in Gilead Sciences in Q2 2016 and held it in 6 quarters.
  • Bangor Savings Bank's Gilead Sciences position peaked at $1.28M in Q2 2017.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Bangor Savings Bank's 13F filing for Q1 2026, filed 1 Apr 2026.